InsidersTradesSigma
Follow the Xvivo Perfusion AB share price and the full insider trade history of the company, a publicly traded company based in Finland. Shares are listed on FI FI, under the oversight of FIN-FSA. Operating in the Health Care sector, Xvivo Perfusion AB has logged 0 reports. Market capitalisation: €7.4bn. All data is accessible without an account.
Analysts rate Xvivo Perfusion AB Strong Buy (bullish), based on 5 analysts. Average price target: SEK 337.40.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
0 of 0 declarations
Xvivo Perfusion AB is a company focused on developing perfusion solutions for organ transplantation. It is listed on the XSTO stock exchange.